| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/26/2006 | CA2574146A1 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line |
| 01/26/2006 | CA2573972A1 Method for increasing the content of polyunsaturated long-chained fatty acids in transgenic organisms |
| 01/26/2006 | CA2573676A1 Plants having improved growth characteristics and method for making the same |
| 01/26/2006 | CA2573494A1 Control of biofilm formation |
| 01/26/2006 | CA2573490A1 Production of flavonoids by recombinant microorganisms |
| 01/26/2006 | CA2570990A1 Expression-enhanced polypeptides |
| 01/26/2006 | CA2570602A1 Agents for regulating the activity of interferon-producing cells |
| 01/26/2006 | CA2570114A1 Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to hiv |
| 01/26/2006 | CA2565306A1 Plant galactinol synthase homologs |
| 01/25/2006 | EP1619259A2 Sequencing method using magnifying tags |
| 01/25/2006 | EP1619254A1 Transfer of mRNA using polycationic compounds |
| 01/25/2006 | EP1619253A1 Gene trap system |
| 01/25/2006 | EP1619252A1 L-lysine producing coryneform bacteria and methods for the production of L-lysine |
| 01/25/2006 | EP1619251A1 A mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapy |
| 01/25/2006 | EP1619250A1 WSX receptor and ligands |
| 01/25/2006 | EP1619249A1 Induction of exon skipping in eukaryotic cells |
| 01/25/2006 | EP1619248A1 Mouse with deficiency of glutamate transporter glast function |
| 01/25/2006 | EP1619243A1 Implement and method for freezing and storing egg |
| 01/25/2006 | EP1619241A1 Genetic modification system for myxobacteria |
| 01/25/2006 | EP1619208A1 Chaperonine-target protein complex, method of producing the same, method of stabilizing target protein, method of immobilizing target protein, method of analyzing the structure of target protein, sustained-release preparation and method of producing antibody against target protein |
| 01/25/2006 | EP1619207A2 HLA-A2.1 binding peptides derived from HCV and their uses |
| 01/25/2006 | EP1619202A2 immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/25/2006 | EP1618898A2 Methods for regulating angiogenesis |
| 01/25/2006 | EP1618888A1 Production of human papillomavirus capsid protein and virus-like particles |
| 01/25/2006 | EP1618212A1 Mutations in the human pcsk9 gene associated to hypercholesterolemia |
| 01/25/2006 | EP1618201A1 Vp2 - modified raav vectors and uses thereof |
| 01/25/2006 | EP1618200A1 Tissue specific promoters |
| 01/25/2006 | EP1618199A2 Affinity purification system using troponin molecules as affinity ligands |
| 01/25/2006 | EP1618198A1 Chalcone synthase dihydroflavonol 4-reductase and leucoanthocyanidine reductase from clover, medic ryegrass or fescue |
| 01/25/2006 | EP1618197A2 Canine ghrh gene, polypeptides and methods of use |
| 01/25/2006 | EP1618196A2 Dna-based aptamers for human cathepsin g |
| 01/25/2006 | EP1618195A2 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through antisense and antigen peptido-nucleic acids (pna) |
| 01/25/2006 | EP1618194A2 Compositions and methods for using a solid support to purify rna |
| 01/25/2006 | EP1618193A1 Use of genes for increasing the oil content in plants |
| 01/25/2006 | EP1618191A2 Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/25/2006 | EP1618189A2 Rnai agents for anti-sars coronavirus therapy |
| 01/25/2006 | EP1618186A2 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype |
| 01/25/2006 | EP1618181A2 Polyvalent protein complex |
| 01/25/2006 | EP1618179A2 Polymer-conjugated glycosylated neublastin |
| 01/25/2006 | EP1618177A2 Production of high mannose proteins in plant culture |
| 01/25/2006 | EP1618132A2 Composition and methods for the treatment of immune disorders |
| 01/25/2006 | EP1617829A2 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 01/25/2006 | EP1617808A2 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
| 01/25/2006 | EP1617802A2 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses. |
| 01/25/2006 | EP1571897A4 Generation of plants with altered oil content |
| 01/25/2006 | EP1485490A4 Yield-related polynucleotides and polypeptides in plants |
| 01/25/2006 | EP1474430B1 Bi-functionalised metallocenes use for marking biological molecules |
| 01/25/2006 | EP1461071A4 Muscle transcription factors |
| 01/25/2006 | EP1393066A4 Insulin producing cells derived from human embryonic stem cells |
| 01/25/2006 | EP1212462B1 Methods of determining the presence of double stranded nucleic acids in a sample |
| 01/25/2006 | EP1204738B1 A method for decreasing the foam formation during cultivation of a microorganism |
| 01/25/2006 | EP1190068B1 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 01/25/2006 | EP1151121B1 Recombined porcine adenovirus based viral vaccines and vectors |
| 01/25/2006 | EP1144650B1 Goodpasture antigen binding protein |
| 01/25/2006 | EP1080202B1 Convection-enhanced delivery of aav vectors encoding aadc |
| 01/25/2006 | EP1071798B1 Constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 01/25/2006 | EP1051495B1 Recombinant mistletoe lectines |
| 01/25/2006 | EP0980427B1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 01/25/2006 | EP0759694B1 Method for in vivo delivery of therapeutic agents via liposomes |
| 01/25/2006 | CN1726290A Method for generating a genetically modified organism for screening active substances |
| 01/25/2006 | CN1726287A Method of distinguishing drug-resistance of hepatitis b virus |
| 01/25/2006 | CN1726285A Methods and compositions for immunization against HIV |
| 01/25/2006 | CN1726283A Production of multimeric fusion proteins using a C4BP scaffold |
| 01/25/2006 | CN1726282A Plant cells and plants which synthesize a starch with an increased final viscosity |
| 01/25/2006 | CN1726281A IL-21 production in prokaryotic hosts |
| 01/25/2006 | CN1726280A Thermostable alpha-amylases |
| 01/25/2006 | CN1726278A Laser driver circuit and system |
| 01/25/2006 | CN1726276A Production of ALVAC on avian embryonic stem cells |
| 01/25/2006 | CN1726228A Monitor protein for measuring processing of protein |
| 01/25/2006 | CN1726227A Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with 1L-2 |
| 01/25/2006 | CN1726046A Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 01/25/2006 | CN1724677A Expression system of in vitro culturing skeletal muscle |
| 01/25/2006 | CN1724676A Method of diploid, tetraploid wead converting bivalent anti insect gene |
| 01/25/2006 | CN1724675A Method of regulating and controlling plant lignin content |
| 01/25/2006 | CN1724674A Expression method of insect defensin in pichia |
| 01/25/2006 | CN1724673A Expression method of America poke root antivirus protein (PAR) in pasteur pichia |
| 01/25/2006 | CN1724672A Constitution type expression carrier and its application |
| 01/25/2006 | CN1724671A Recombination human endothelium chalene expression strain and solubility expression method |
| 01/25/2006 | CN1724670A H9N2 type poultry influenze NS1 protein expression plasmid pET-NS1 |
| 01/25/2006 | CN1724669A Method in increasing oleic acid content of soybean and peanut seed by applying gene silent technology |
| 01/25/2006 | CN1724668A Paddy rice Osfad 8 coded sequence and its application |
| 01/25/2006 | CN1724667A Paddy rice zinc finger protein gene and its coded protein |
| 01/25/2006 | CN1724666A Immune tbid gene and its coded protein and application |
| 01/25/2006 | CN1724665A Human new gene TRIKS and its coded protein |
| 01/25/2006 | CN1724664A Human HOLF 402 protein and its coding sequence |
| 01/25/2006 | CN1724663A Method of preparing natural human thymosin a1 using series expression mode |
| 01/25/2006 | CN1724654A Establishent of acacia crassicarpa high efficiency transforming system induced by agricultural bacillus |
| 01/25/2006 | CN1724570A Anthrax toxin acceptor ATR-Fc fusion protein |
| 01/25/2006 | CN1724565A Barley yellow dwarf virus mediator ophid body and toxin transmission related protein and its application |
| 01/25/2006 | CN1724564A Primary structure of snake origin deintegration element mutant anti human platelet aggregation medicine health beneficial protein |
| 01/25/2006 | CN1238520C Crystal structure of cPLAz and methods of identifying agonists and antagonists using same |
| 01/25/2006 | CN1238519C Process for producing nucleoside compound |
| 01/25/2006 | CN1238515C L-glutamic acid-producing method |
| 01/25/2006 | CN1238513C Method for lowering pollen fertility by using tapetum specific zinc finger transcription factor gene |
| 01/25/2006 | CN1238512C Method for preparing connective tissue growth factor C-zone antigen |
| 01/25/2006 | CN1238511C Promotor of gene of cytoplasm type 1,6 diphosphate fructose enzyme and its application |
| 01/25/2006 | CN1238510C Artificial synthetic Bt anti-insect gene used for transgene anti-insect plant and its development method |
| 01/25/2006 | CN1238509C Zmpl for corn growth and its use |
| 01/25/2006 | CN1238508C Distillersyeast recombined hepatitis B virus surface antigen stream addition femrentation process |
| 01/25/2006 | CN1238507C 6 gene of neurenergen sourced from human, and application of maturation peptide fragment expressed by the gene |